1- Peng, J., Fan, M., An, C., Ni, F., Huang, W., & Luo, J. (2022). A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD). Basic & Clinical Pharmacology & Toxicology, 130(4), 439-456.
2-Pertwee, R. (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin. British journal of pharmacology, 153(2), 199-215.
3-Tsuboi, K., Uyama, T., Okamoto, Y., & Ueda, N. (2018). Endocannabinoids and related N-acylethanolamines: biological activities and metabolism. Inflammation and Regeneration, 38, 1-10.
4-Reggio, P. H. (2010). Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown. Current medicinal chemistry, 17(14), 1468-1486.
5-Anthony, A. T., Rahmat, S., Sangle, P., Sandhu, O., & Khan, S. (2020). Cannabinoid receptors and their relationship with chronic pain: a narrative review. Cureus, 12(9).
6- Peres, F. F., Lima, A. C., Hallak, J. E., Crippa, J. A., Silva, R. H., & Abílio, V. C. (2018). Cannabidiol as a promising strategy to treat and prevent movement disorders?. Frontiers in pharmacology, 9, 482.
7-Bakas, T., Van Nieuwenhuijzen, P. S., Devenish, S. O., McGregor, I. S., Arnold, J. C., & Chebib, M. (2017). The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABAA receptors. Pharmacological research, 119, 358-370.
8-Rajan, T. S., Giacoppo, S., Iori, R., De Nicola, G. R., Grassi, G., Pollastro, F., … & Mazzon, E. (2016). Anti-inflammatory and antioxidant effects of a combination of cannabidiol and moringin in LPS-stimulated macrophages. Fitoterapia, 112, 104-115.
9-Giacoppo, S., Pollastro, F., Grassi, G., Bramanti, P., & Mazzon, E. (2017). Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis. Fitoterapia, 116, 77-84.
10-Rajan, T. S., Giacoppo, S., Iori, R., De Nicola, G. R., Grassi, G., Pollastro, F., … & Mazzon, E. (2016). Anti-inflammatory and antioxidant effects of a combination of cannabidiol and moringin in LPS-stimulated macrophages. Fitoterapia, 112, 104-115.
11-Hampson, A. J., Grimaldi, M., Axelrod, J., & Wink, D. (1998). Cannabidiol and (−) Δ9-tetrahydrocannabinol are neuroprotective antioxidants. Proceedings of the National Academy of Sciences, 95(14), 8268-8273.
12- Katchan, V., David, P., & Shoenfeld, Y. (2016). Cannabinoids and autoimmune diseases: A systematic review. Autoimmunity reviews, 15(6), 513-528.
13-Mlost, J., Bryk, M., & Starowicz, K. (2020). Cannabidiol for pain treatment: focus on pharmacology and mechanism of action. International journal of molecular sciences, 21(22), 8870
14 -Aviram, J., & Samuelly-Leichtag, G. (2017). Efficacy of cannabis-based medicines for pain management: a systematic review and meta-analysis of randomized controlled trials. Pain physician, 20(6), E755.
15 -Sainsbury, B., Bloxham, J., Pour, M. H., Padilla, M., & Enciso, R. (2021). Efficacy of cannabis-based medications compared to placebo for the treatment of chronic neuropathic pain: a systematic review with meta-analysis. Journal of dental anesthesia and pain medicine, 21(6), 479.
16 -Johal, H., Devji, T., Chang, Y., Simone, J., Vannabouathong, C., & Bhandari, M. (2020). Cannabinoids in chronic non-cancer pain: a systematic review and meta-analysis. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders, 13, 1179544120906461.
17 –Ambriz-Tututi, M., Rocha-González, H. I., Cruz, S. L., & Granados-Soto, V. (2009). Melatonin: a hormone that modulates pain. Life sciences, 84(15-16), 489-498.
18 –Andersen, L. P., Gögenur, I., Fenger, A. Q., Petersen, M. C., Rosenberg, J., & Werner, M. U. (2015). Analgesic and antihyperalgesic effects of melatonin in a human inflammatory pain model: a randomized, double-blind, placebo-controlled, three-arm crossover study. Pain, 156(11), 2286-2294.
19 –Zhang, L., Zhang, J. T., Huang, Y., Zhou, G. K., Zhou, Y., Yang, J. P., & Liu, T. (2022). Melatonin attenuates acute and chronic itch in mice: the antioxidant and anti-inflammatory effects of melatonin receptors. Annals of translational medicine, 10(18).
20 –Adkison, J. D., Bauer, D. W., & Chang, T. (2010). The effect of topical arnica on muscle pain. Annals of Pharmacotherapy, 44(10), 1579-1584.
21 –Iannitti, T., Morales-Medina, J. C., Bellavite, P., Rottigni, V., & Palmieri, B. (2016). Effectiveness and safety of Arnica montana in post-surgical setting, pain and inflammation. American journal of therapeutics, 23(1), e184-e197.
22 –Pergolizzi Jr, J. V., Taylor Jr, R., LeQuang, J. A., Raffa, R. B., & NEMA Research Group. (2018). The role and mechanism of action of menthol in topical analgesic products. Journal of clinical pharmacy and therapeutics, 43(3), 313-319.
23 –Wasner, G., Schattschneider, J., Binder, A., & Baron, R. (2004). Topical menthol—a human model for cold pain by activation and sensitization of C nociceptors. Brain, 127(5), 1159-1171.
24 –Eshghi, F., Hosseinimehr, S. J., Rahmani, N., Khademloo, M., Norozi, M. S., & Hojati, O. (2010). Effects of Aloe vera cream on posthemorrhoidectomy pain and wound healing: results of a randomized, blind, placebo-control study. The Journal of Alternative and Complementary Medicine, 16(6), 647-650.
25 –Maleki, A., & Youseflu, S. (2022). The Effectiveness of Aloe Vera on Relief of Irritation and Nipple Pain in Lactating Women: Systematic Review and Meta‐Analysis. Obstetrics and gynecology international, 2022(1), 7430581.
1 valoración en Efi-CBD Cream
Ana F –
Maravillosa para cuando me paso entrenando y me duele todo.